Search research articles
Contact Us
Filters
Showing results (91-100 of 139) with videos related to
Page
of 14
Sort By:
JAMA Network Open
|
June 1, 2026
Digital Self-Management of Symptoms and Quality of Life for Patients With Advanced Cancer: A Randomized Clinical Trial
Wing-Lok Chan, Inda Sung Soong, Mei-Ying Lim, et al.
British Journal of Cancer
|
September 19, 2019
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes
John Malcolm Nicholls, Victor Ho-Fun Lee, Sik-Kwan Chan, et al.
Osteoporosis and Sarcopenia
|
May 17, 2021
Sarcopenia and mortality in different clinical conditions: A meta-analysis
Grace Koon-Yee Lee, Philip Chun-Ming Au, Gloria Hoi-Yee Li, et al.
Osteoporosis and Sarcopenia
|
May 17, 2021
Different definition of sarcopenia and mortality in cancer: A meta-analysis
Hang-Long Li, Philip Chun-Ming Au, Grace Koon-Yee Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 18, 2024
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer
Chi Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li, et al.
Cancers
|
January 8, 2023
Quantitative Spatial Characterization of Lymph Node Tumor for N Stage Improvement of Nasopharyngeal Carcinoma Patients
Jiang Zhang, Xinzhi Teng, Saikit Lam, et al.
Cancer Medicine
|
February 3, 2026
Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122
Anthony T C Chan, Victor Ho Fun Lee, Ruey-Long Hong, et al.
BMC Infectious Diseases
|
November 11, 2021
Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report
Kin-Sang Lau, Ben Man-Fei Cheung, Ka-On Lam, et al.
Cancers
|
April 23, 2022
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma
Sik-Kwan Chan, Brian O'Sullivan, Shao Hui Huang, et al.
JCO Precision Oncology
|
July 1, 2026
Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma
Huaping Li, Qiuyu Jing, James Chung Hang Chow, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 139) with videos related to
Sort By:
Page
of 14
JAMA Network Open
|
June 1, 2026
Digital Self-Management of Symptoms and Quality of Life for Patients With Advanced Cancer: A Randomized Clinical Trial
Wing-Lok Chan, Inda Sung Soong, Mei-Ying Lim, et al.
British Journal of Cancer
|
September 19, 2019
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes
John Malcolm Nicholls, Victor Ho-Fun Lee, Sik-Kwan Chan, et al.
Osteoporosis and Sarcopenia
|
May 17, 2021
Sarcopenia and mortality in different clinical conditions: A meta-analysis
Grace Koon-Yee Lee, Philip Chun-Ming Au, Gloria Hoi-Yee Li, et al.
Osteoporosis and Sarcopenia
|
May 17, 2021
Different definition of sarcopenia and mortality in cancer: A meta-analysis
Hang-Long Li, Philip Chun-Ming Au, Grace Koon-Yee Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 18, 2024
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer
Chi Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li, et al.
Cancers
|
January 8, 2023
Quantitative Spatial Characterization of Lymph Node Tumor for N Stage Improvement of Nasopharyngeal Carcinoma Patients
Jiang Zhang, Xinzhi Teng, Saikit Lam, et al.
Cancer Medicine
|
February 3, 2026
Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122
Anthony T C Chan, Victor Ho Fun Lee, Ruey-Long Hong, et al.
BMC Infectious Diseases
|
November 11, 2021
Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report
Kin-Sang Lau, Ben Man-Fei Cheung, Ka-On Lam, et al.
Cancers
|
April 23, 2022
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma
Sik-Kwan Chan, Brian O'Sullivan, Shao Hui Huang, et al.
JCO Precision Oncology
|
July 1, 2026
Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma
Huaping Li, Qiuyu Jing, James Chung Hang Chow, et al.
Page
of 14